InterCure Ltd. (INCR) vs XBiotech Inc. (XBIT)
A side-by-side comparison of InterCure Ltd. and XBiotech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INCR
InterCure Ltd.
$5.32HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XBIT
XBiotech Inc.
$2.16HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — INCR vs XBIT
growth of $100 · dividends reinvested · last 8yINCR -68.0% (-13.3%/yr)XBIT -60.0% (-10.8%/yr)XBIT compounded faster over this window
INCR XBIT
INCR vs XBIT: by the numbers
- •XBIT is the larger company ($66M vs $63M market cap).
- •Both run net losses; XBIT's is the smaller (0.00% vs -13.72% net margin).
Metrics side by side
Valuation
| Metric | INCR | XBIT |
|---|---|---|
| P/S ratio | 0.79 | N/A |
| P/B ratio | 0.51 | 0.51 |
| FCF yield | 11.66% | N/A |
Profitability
| Metric | INCR | XBIT |
|---|---|---|
| Gross margin | 14.40% | 0.00% |
| Operating margin | 2.49% | 0.00% |
| Net margin | -13.72% | 0.00% |
| ROE | -8.80% | -35.13% |
| ROIC | -4.72% | -37.01% |
Growth (annualized)
| Metric | INCR | XBIT |
|---|---|---|
| Revenue CAGR (5Y) | 32.71% | N/A |
| Total return CAGR (5Y) | -30.85% | -29.36% |
Frequently asked
- How have INCR and XBIT total returns compared?
- Over the past 5 years, INCR delivered -30.85% and XBIT delivered -29.36% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
InterCure ROEXBiotech ROEInterCure operating marginXBiotech operating marginInterCure revenue growthXBiotech revenue growthInterCure free cash flowXBiotech free cash flow
InterCure & XBiotech appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.